| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |